First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study
Titel:
First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study
Auteur:
Feher, O. Vodvarka, P. Jassem, J. Morack, G. Advani, S.H. Khoo, K.S. Doval, D.C. Ermisch, S. Roychowdhury, D. Miller, M.A. von Minckwitz, G.